Retraction notice regarding several articles published in Tumor Biology.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

Corrections and comments

• Retraction of
  Phyllodes tumor of the breast: role of Axl and ST6GalNAcII in the development of mammary phyllodes tumors.2014
• Retraction of
  Axl as a downstream effector of TGF-β1 via PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and chemoresistance in breast carcinoma.2015
• Retraction of
  Adenovirus type 12 E1B 55-kilodalton oncoprotein promotes p53-mediated apoptotic response of ovarian cancer to cisplatin.2015
• Retraction of
  MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma.2015
• Retraction of
  Pokemon and MEF2D co-operationally promote invasion of hepatocellular carcinoma.2015
• Retraction of
  Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer.2016
• Retraction of
  MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.2016
• Retraction of
  miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma.2016
• Retraction of
  MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1.2016
• Retraction of
  Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.2016
• Retraction of
  miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.2016
• Retraction of
  Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2.2016
• Retraction of
  Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.2016
• Retraction of
  miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3.2016
• Retraction of
  Effects of RNAi-mediated TUSC3 silencing on radiation-induced autophagy and radiation sensitivity of human lung adenocarcinoma cell line A549 under hypoxic condition.2016

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract